Bernard Siegel is the founder and executive director of the Genetics Policy Institute. He is an internationally known legal activist working to promote supportive legislation for stem cell research throughout the U.S. and the world. He is an authority on regulations pertaining to cloning technologies and has built an international constituency of scientists, bioethicists, legal scholars and patient-advocates for the promotion of stem cell research.

A member of the Florida Bar for nearly three decades, in 2002 Mr. Siegel filed the landmark case against the organization Clonaid, initiating the first legal action to oppose the reproductive cloning of humans. While opposing human reproductive cloning, he has led the effort to keep therapeutic cloning for the purpose of stem cell research legal in the United States and throughout the world. Working with the world's leading scientific authorities on therapeutic cloning and stem cell research, Mr. Siegel has been instrumental in educating the United Nations General Assembly about the promise of therapeutic cloning. Mr. Siegel also works with grassroots activists throughout the United States to help educate lawmakers and formulate effective strategies for the support of therapeutic cloning and embryonic stem cell research.

Mr. Siegel has appeared on the CBS Evening News with Dan Rather, CNN, CNN International, MSNBC, Fox and Friends and network news shows throughout the U.S. and the world. He was profiled on National Public Radio's All Things Considered. He has been quoted in the New York Times, The Washington Post, The Boston Globe, The Scientist, New Scientist, The London Times, Le Monde, Pravda, The Peoples Daily and many other publications.